155 related articles for article (PubMed ID: 12218080)
21. Association of Epstein-Barr virus with oral cancers.
Shimakage M; Horii K; Tempaku A; Kakudo K; Shirasaka T; Sasagawa T
Hum Pathol; 2002 Jun; 33(6):608-14. PubMed ID: 12152159
[TBL] [Abstract][Full Text] [Related]
22. Epstein-Barr virus infection and its gene expression in gastric lymphoma of mucosa-associated lymphoid tissue.
Xu WS; Chan AC; Lee JM; Liang RH; Ho FC; Srivastava G
J Med Virol; 1998 Dec; 56(4):342-50. PubMed ID: 9829640
[TBL] [Abstract][Full Text] [Related]
23. Expression of Epstein-Barr virus in Langerhans' cell histiocytosis.
Shimakage M; Sasagawa T; Kimura M; Shimakage T; Seto S; Kodama K; Sakamoto H
Hum Pathol; 2004 Jul; 35(7):862-8. PubMed ID: 15257550
[TBL] [Abstract][Full Text] [Related]
24. Epidemiological study, immunohistochemistry and in situ hybridization studies of nasopharyngeal carcinomas: a Tunisian report.
Hila L; Farah F; Ayari H; Ferjaoui M; Dehria W; Ben Jilani S
Pathol Biol (Paris); 2009 Jul; 57(5):427-9. PubMed ID: 18835109
[TBL] [Abstract][Full Text] [Related]
25. Molecular detection of Epstein-Barr virus in different types of lymphoma.
Shaklawoon K; Altagazi N; Altorjman F; Alturki A; Eltaweel M; Alqawi O
Mol Biol Rep; 2020 Mar; 47(3):1803-1807. PubMed ID: 31993862
[TBL] [Abstract][Full Text] [Related]
26. Nucleic acid sequence-based amplification, a new method for analysis of spliced and unspliced Epstein-Barr virus latent transcripts, and its comparison with reverse transcriptase PCR.
Brink AA; Vervoort MB; Middeldorp JM; Meijer CJ; van den Brule AJ
J Clin Microbiol; 1998 Nov; 36(11):3164-9. PubMed ID: 9774558
[TBL] [Abstract][Full Text] [Related]
27. Heterogeneous, restricted patterns of Epstein-Barr virus (EBV) latent gene expression in patients with chronic active EBV infection.
Yoshioka M; Ishiguro N; Ishiko H; Ma X; Kikuta H; Kobayashi K
J Gen Virol; 2001 Oct; 82(Pt 10):2385-2392. PubMed ID: 11562532
[TBL] [Abstract][Full Text] [Related]
28. Lack of evidence for an association of Epstein-Barr virus infection with breast carcinoma.
Herrmann K; Niedobitek G
Breast Cancer Res; 2003; 5(1):R13-7. PubMed ID: 12559053
[TBL] [Abstract][Full Text] [Related]
29. High prevalence of Epstein-Barr virus in the Reed-Sternberg cells of Hodgkin's disease occurring in Peru.
Chang KL; Albújar PF; Chen YY; Johnson RM; Weiss LM
Blood; 1993 Jan; 81(2):496-501. PubMed ID: 8380728
[TBL] [Abstract][Full Text] [Related]
30. Epstein-Barr virus and Hodgkin's disease: a comparative immunological, in situ hybridization, and polymerase chain reaction study.
Lauritzen AF; Hørding U; Nielsen HW
APMIS; 1994 Jul; 102(7):495-500. PubMed ID: 7917218
[TBL] [Abstract][Full Text] [Related]
31. Restricted expression of Epstein-Barr virus (EBV)-encoded, growth transformation-associated antigens in an EBV- and human herpesvirus type 8-carrying body cavity lymphoma line.
Szekely L; Chen F; Teramoto N; Ehlin-Henriksson B; Pokrovskaja K; Szeles A; Manneborg-Sandlund A; Löwbeer M; Lennette ET; Klein G
J Gen Virol; 1998 Jun; 79 ( Pt 6)():1445-52. PubMed ID: 9634087
[TBL] [Abstract][Full Text] [Related]
32. No significant role of Epstein-Barr virus in the tumorigenesis of Warthin tumor.
Ogata T; Hongfang Y; Kayano T; Hirai K
J Med Dent Sci; 1997 Jun; 44(2):45-52. PubMed ID: 9608281
[TBL] [Abstract][Full Text] [Related]
33. Suppression of Epstein-Barr nuclear antigen 1 (EBNA1) by RNA interference inhibits proliferation of EBV-positive Burkitt's lymphoma cells.
Hong M; Murai Y; Kutsuna T; Takahashi H; Nomoto K; Cheng CM; Ishizawa S; Zhao QL; Ogawa R; Harmon BV; Tsuneyama K; Takano Y
J Cancer Res Clin Oncol; 2006 Jan; 132(1):1-8. PubMed ID: 16180023
[TBL] [Abstract][Full Text] [Related]
34. Expression of Epstein-Barr virus latent gene products and related cellular activation and adhesion molecules in Hodgkin's disease and non-Hodgkin's lymphomas arising in patients without overt pre-existing immunodeficiency.
Kanavaros P; Jiwa M; van der Valk P; Walboomers J; Horstman A; Meijer CJ
Hum Pathol; 1993 Jul; 24(7):725-9. PubMed ID: 8100553
[TBL] [Abstract][Full Text] [Related]
35. Assessment of the methods for the detection of Epstein-Barr virus nucleic acids and related gene products in Hodgkin's disease.
Brousset P; Meggetto F; Chittal S; Bibeau F; Arnaud J; Rubin B; Delsol G
Lab Invest; 1993 Oct; 69(4):483-90. PubMed ID: 8231115
[TBL] [Abstract][Full Text] [Related]
36. Comparison of in situ hybridization using different nonisotopic probes for detection of Epstein-Barr virus in nasopharyngeal carcinoma and immunohistochemical correlation with anti-latent membrane protein antibody.
Brousset P; Butet V; Chittal S; Selves J; Delsol G
Lab Invest; 1992 Oct; 67(4):457-64. PubMed ID: 1331609
[TBL] [Abstract][Full Text] [Related]
37. Expression of Epstein-Barr virus in cutaneous T-cell lymphoma including mycosis fungoides.
Shimakage M; Sasagawa T; Kawahara K; Yutsudo M; Kusuoka H; Kozuka T
Int J Cancer; 2001 Apr; 92(2):226-31. PubMed ID: 11291050
[TBL] [Abstract][Full Text] [Related]
38. [Epstein Barr virus and invasive mammary carcinomas: EBNA, EBERs and molecular profile in a population of West Algeria].
Yahia R; Zaoui C; Derbale W; Boudi H; Chebloune Y; Sahraoui T; Elkebir FZ
Ann Biol Clin (Paris); 2018 Jan; 76(1):75-80. PubMed ID: 29336321
[TBL] [Abstract][Full Text] [Related]
39. Analysis of Epstein-Barr virus strains and variants in classical Hodgkin's lymphoma by laser microdissection.
García-Cosío M; Santón A; Martín P; Reguero ME; Cristóbal E; Bellas C
Histol Histopathol; 2008 Feb; 23(2):209-17. PubMed ID: 17999377
[TBL] [Abstract][Full Text] [Related]
40. Clinical and pathological characterization of Epstein-Barr virus-associated gastric carcinomas in Portugal.
Ribeiro J; Oliveira A; Malta M; Oliveira C; Silva F; Galaghar A; Afonso LP; Neves MC; Medeiros R; Pimentel-Nunes P; Sousa H
World J Gastroenterol; 2017 Oct; 23(40):7292-7302. PubMed ID: 29142476
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
